Synthon Hispania, S.L. (quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used in non-transfusion-dependent thalassemia syndromes if deferoxamine therapy is ineffective or contraindicated.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 90 mg ATC: V03AC03
-
The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used to treat iron overload in patients with transfusion-independent thalassemia syndromes if deferoxamine therapy is contraindicated or ineffective.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 180 mg ATC: V03AC03
-
The drug is prescribed for the treatment of chronic iron overload in patients with beta-thalassemia or other anemias requiring regular blood transfusions. It is also used to treat iron overload in patients with transfusion-independent thalassemia syndromes.
Dosage form: tablets, film-coated
Active substance Dosage deferasirox 360 mg ATC: V03AC03